BVS - Bioventus Global Market Cap to Earnings and Growth Ratio
Diversification between sports medicine and surgery minimizes industry risks, while unique patents in bone regeneration allow Bioventus Inc. (BVS) to maintain premium pricing power. After examining the company's current PEG valuation on GURU.Markets, we find that 0.81 determines the latest valuation metric. Business stability is ensured by planned capacity utilization and the automation of packaging within sterile zones.
%20PEG%20Multiple&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_BVS_-_Bioventus-Inc._-_PEG-Multiple "BVS - bioventus.com Price to Earnings Adjusted for Growth Rate over the range 07/04/2022 - 11/12/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Bioventus Inc. (BVS)
- price and consensus price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Bioventus Inc.|BVS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio bioventus.com|BVS - Company Aggregate Debts|Debts to Book Value Bioventus Corp|BVS - Company Long-Term Debts|Company Short-Term Indebtedness Bioventus|Interim Coverage Ratio bioventus.com
- earnings and multiples data:
BVS - Net Profit|Future Profit Bioventus Inc.|BVS - P/E Multiple|Forward P/E Multiple Bioventus Global|BVS - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bioventus Corp|BVS - Operating profit before deduction of amortization|Earnings per share for the trailing year Bioventus|BVS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months bioventus.com|BVS - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Bioventus Inc.
General company analysis:BVS - Bioventus Inc
Steady demand for Bioventus Inc. (BVS) orthopedic products makes the growth-normalized P/E an effective tool for analyzing the stability of the company's capitalization. This indicator correlates market value with earnings growth rates: a value below one signals that the asset is undervalued relative to its operational dynamics, highlighting potentially fast-growing securities with strong macroeconomic defensive qualities.
Competing companies
Growth-Adjusted Market Cap to Net Income Boston Scientific Corp|Edwards Lifesciences Corp - Price/Earnings to Growth Multiple|RMD (ResMed Corporation) - Market Cap to Earnings and Growth Ratio|Insulet Corporation - PEG Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Holdings Inc|COO: PEG Multiple|Growth-Adjusted P/E Ratio ALGN|Price/Earnings to Growth Multiple GMED|TMDX: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Alphatec Holdings, Inc. (ATEC)|Price/Earnings to Growth Multiple artivion.com AORT|PEG Multiple ENOV (Enovis)|Integra LifeSciences Corp (IART) - Price to Earnings Adjusted for Growth Rate|Motiva - PEG Multiple|BBNX (iLet Bionic Pancreas) - Growth-Adjusted P/E Ratio|IRMD: PEG Multiple|EMBC - Growth-Adjusted Market Cap to Net Income|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|Price/Earnings to Growth Multiple AxoGen Inc (AXGN)|PEG Multiple SIBN|PEG Multiple Orthofix Corp (OFIX)|Price/Earnings to Growth Ratio OrthoPediatrics KIDS|treace.com - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CARL (Carlsmed, Inc.)|RXST: PEG Multiple|Price to Earnings Adjusted for Growth Rate ClearPoint Neuro (CLPT)|Price/Earnings to Growth Ratio Stereotaxis, Inc.|STIM - Price to Net Income Growth Ratio|Price/Earnings to Growth Multiple SGHT (Sight Sciences)|PEG Multiple Orchestra BioMed Inc. (OBIO)|PEG Multiple ANIK (Anika Therapeutics, Inc.)|Growth-Adjusted Market Cap to Net Income InspireMD Inc. (NSPR)|ZJYL - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple NeuroOne|MODD (Modular Medical Inc) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Myomo Inc MYO|Price/Earnings to Growth Ratio Envoy Medical, Inc. (COCH)|vivoslife.com - Growth-Adjusted P/E Ratio|enVVeno Medical Corp. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio SINT (Sintx Technologies Inc)|Tenon Medical, Inc - PEG Multiple|LFWD: Price/Earnings to Growth Ratio|AMIX: PEG Multiple|IVF - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Bone Biologics Corp|Price to Earnings Adjusted for Growth Rate Axonics Inc. AXNX|Price/Earnings to Growth Multiple BIOL (Biolase, Inc.)|Price/Earnings to Growth Ratio DYNT (dynatronics.com)|PEG Multiple FNA (Paragon 28)|INVO Bioscience Inc. (INVO) - Price to Earnings Adjusted for Growth Rate
